Session Details
[S32★☆]Verification and Quality Assurance of the Six-Year Pharmacy Education Program through Third-Party Evaluation of Pharmacy Education
Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 16 (A101, Bldg. 1, Area 3 [1F])
Organizer: Yoichi Hasegawa (Faculty of Pharm., Meijo Univ.), Yoichiro Arata (Faculty of Pharm. Sci., Teikyo Univ.)
Third-party evaluation of pharmaceutical education commenced in fiscal year 2012. Faculties of pharmacy and pharmaceutical universities undergo evaluation by the Pharmaceutical Education Evaluation Organization every seven years. The third phase of third-party evaluation of pharmaceutical education will begin in fiscal year 2027. The Pharmaceutical Education Evaluation Organization began revising the Phase 3 evaluation criteria in fiscal year 2023. Reflecting the intent of the revised Model Core Curriculum for Pharmaceutical Education adopted in 2022, the Third-Party Evaluation aims to ensure the quality of degree programs within the six-year pharmaceutical education system. Therefore, the focus is on the effectiveness of internal quality assurance, where universities themselves conduct self-assessment and evaluation of their pharmacy education programs and implement improvements based on the results. This symposium will introduce the significance of quality assurance demanded today, a review of past evaluations, and an overview of the Phase 3 evaluation criteria.
挨拶・趣旨説明
長谷川 洋一(名城大薬),荒田 洋一郎(帝京大薬)
[S32-1]The purpose and future direction of third-party evaluation in pharmaceutical education: The role of the accreditation evaluation system
○Kazutaka Kobayashi1 (1. MEXT)
[S32-2]The purpose and future direction of third-party evaluation in pharmaceutical education: the positioning of the pharmaceutical education evaluation organization
○Akira Shirahata1 (1. Josai Univ.)
[S32-3]The role of evaluation in quality assurance in university education: why does internal quality assurance become an end in itself?
○Tsutomu Ymada1 (1. UO SLiCS C.)
[S32-4]Quality assurance of pharmaceutical education based on the evaluation standards of japan accreditation board for pharmaceutical education
○Kazumasa Hirata1 (1. Wakayama Med. Univ.)
[S32-5]A reflection on the 5th year of the second cycle third-party evaluation of pharmaceutical education
○Yoshihisa Tomioka1 (1. Grad. Sch. Pharm. Sci., Tohoku Univ.)
[S32-6]Revision of the third-period evaluation criteria for third-party evaluation of pharmaceutical education and its significance
○Yoichi Hasegawa1 (1. Faculty of Pharm., Meijo Univ.)
